ProtexAging: ProtexAging – New modeling compounds for the treatment of aging-associated diseases (Q2866755)

From EU Knowledge Graph
Revision as of 09:59, 13 September 2021 by DG Regio (talk | contribs) (‎Removed claim: co-financing rate (P837): 76.0 percent, Removing co-finance rate from projects in portugal)
Jump to navigation Jump to search
Project Q2866755 in Portugal
Language Label Description Also known as
English
ProtexAging: ProtexAging – New modeling compounds for the treatment of aging-associated diseases
Project Q2866755 in Portugal

    Statements

    0 references
    6,295.53 Euro
    0 references
    24 January 2020
    0 references
    23 January 2022
    0 references
    UNIVERSIDADE DE COIMBRA
    0 references
    Q2988597 (Deleted Item)
    0 references

    40°12'40.28"N, 8°25'46.06"W
    0 references
    Pretende-se promover a transferência do conhecimento valorizando recursos que podem ser transformados em produtos inovadores e de elevado valor acrescentado para novas terapêuticas para doenças associadas ao envelhecimento, através da proteção da tecnologia por pedido de patente. (Portuguese)
    0 references
    The aim is to promote the transfer of knowledge by valuing resources that can be transformed into innovative and high added value products for new therapies for diseases associated with ageing, through the protection of technology by patent application. (English)
    7 July 2021
    0 references
    Coimbra
    0 references

    Identifiers

    CENTRO-01-0145-FEDER-046792
    0 references